Kanzawa T, Kinoshita F, Namba F, Tanaka T, Oshiro M, Sugiura T
Pediatr Res. 2025; .
PMID: 39900835
DOI: 10.1038/s41390-025-03862-z.
Kinkor M, Schneider J, Sulthana F, Noel-MacDonnell J, Cuna A
J Pediatr Clin Pract. 2024; 14:200129.
PMID: 39629201
PMC: 11613184.
DOI: 10.1016/j.jpedcp.2024.200129.
DeMauro S, Kirpalani H, Ziolkowski K, Hintz S, Watterberg K, Lowe J
BMC Pediatr. 2024; 24(1):737.
PMID: 39543521
PMC: 11562334.
DOI: 10.1186/s12887-024-05198-9.
Raghuveer T, Zackula R, Lakhotia R, Binder S
J Perinatol. 2024; .
PMID: 39223342
DOI: 10.1038/s41372-024-02097-w.
Hebert A, McNamara P, Carvalho Nunes G, Maltais-Bilodeau C, Leclerc M, Wutthigate P
Pediatr Res. 2024; 97(1):325-332.
PMID: 38898108
DOI: 10.1038/s41390-024-03321-1.
Prevention of Inflammatory Disorders in the Preterm Neonate: An Update with a Special Focus on Bronchopulmonary Dysplasia.
Glaser K, Jensen E, Wright C
Neonatology. 2024; 121(5):636-645.
PMID: 38870912
PMC: 11444906.
DOI: 10.1159/000539303.
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M, van Kaam A, Offringa M, Doyle L, Cooper C, Onland W
Cochrane Database Syst Rev. 2024; 4:CD013271.
PMID: 38597338
PMC: 11005325.
DOI: 10.1002/14651858.CD013271.pub2.
Use of surfactant beyond respiratory distress syndrome, what is the evidence?.
Desai R, Yildiz Atar H, Lakshminrusimha S, Ryan R
J Perinatol. 2024; 44(4):478-487.
PMID: 38459371
DOI: 10.1038/s41372-024-01921-7.
The impact of early tracheostomy on neurodevelopmental outcomes of infants with severe bronchopulmonary dysplasia exposed to postnatal corticosteroids.
Taha A, Akangire G, Noel-MacDonnell J, Gladdis T, Manimtim W
J Perinatol. 2023; 44(7):979-987.
PMID: 38158399
DOI: 10.1038/s41372-023-01864-5.
Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia.
Al-Taweel H, Abdelhady I, Irfan N, Al Khzzam F, Kamal A, Thazhe S
Front Pediatr. 2023; 11:1261316.
PMID: 38027255
PMC: 10644707.
DOI: 10.3389/fped.2023.1261316.
Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia.
Bulbul A, Bacak T, Avsar H
Sisli Etfal Hastan Tıp Bul. 2023; 57(2):171-181.
PMID: 37899802
PMC: 10600625.
DOI: 10.14744/SEMB.2023.80688.
EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?.
Nelin T, Bamat N
Acta Paediatr. 2023; 112(12):2620-2621.
PMID: 37740525
PMC: 10885813.
DOI: 10.1111/apa.16977.
The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics.
Baud O, Lehert P
Pediatr Res. 2023; 95(1):251-256.
PMID: 37653218
PMC: 10798883.
DOI: 10.1038/s41390-023-02785-x.
Glucocorticoid signature of preterm infants developing bronchopulmonary dysplasia.
Romijn M, Onland W, van Keulen B, Heijboer A, Rotteveel J, van Kaam A
Pediatr Res. 2023; 94(5):1804-1809.
PMID: 37355738
DOI: 10.1038/s41390-023-02690-3.
Impact of postnatal steroids on peripheral avascular retina and severity of retinopathy of prematurity.
Shekhawat P, Ali M, Kannekanti N, Koechley H, Mhanna C, Pinto M
Pediatr Res. 2023; 94(6):1966-1972.
PMID: 37291231
DOI: 10.1038/s41390-023-02673-4.
Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis....
Gentle S, Rysavy M, Li L, Laughon M, Patel R, Jensen E
JAMA Netw Open. 2023; 6(5):e2315315.
PMID: 37256621
PMC: 10233424.
DOI: 10.1001/jamanetworkopen.2023.15315.
Preterm lung and brain responses to mechanical ventilation and corticosteroids.
Hillman N, Jobe A
J Perinatol. 2023; 43(10):1222-1229.
PMID: 37169913
DOI: 10.1038/s41372-023-01692-7.
Trends, Characteristic, and Outcomes of Preterm Infants Who Received Postnatal Corticosteroid: A Cohort Study from 7 High-Income Countries.
Parikh S, Reichman B, Kusuda S, Adams M, Lehtonen L, Vento M
Neonatology. 2023; 120(4):517-526.
PMID: 37166345
PMC: 10614478.
DOI: 10.1159/000530128.
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
Manley B, Kamlin C, Donath S, Huang L, Birch P, Cheong J
Trials. 2023; 24(1):320.
PMID: 37161488
PMC: 10169381.
DOI: 10.1186/s13063-023-07257-5.
Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Jensen E, Wiener L, Rysavy M, Dysart K, Gantz M, Eichenwald E
JAMA Netw Open. 2023; 6(5):e2312277.
PMID: 37155165
PMC: 10167571.
DOI: 10.1001/jamanetworkopen.2023.12277.
